We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




DNA-based Microarray Identifies Dynamic Microbes

By LabMedica International staff writers
Posted on 13 Oct 2011
Two methods that are independent of polymerase chain reactions (PCRs) have been developed to identify microbial communities. More...


The methods use a high-density microarray with direct hybridization of 16S rRNA (dirRNA) or ribosomal RNA (rRNA) converted to double-stranded complementary DNA (dscDNA).

Scientist from Lawrence Berkeley [US] National Laboratory (Berkeley, CA, USA) identified the individual microbial taxa in a sample via the genetic signatures of the rRNA, which is the genetic component of the ribosome, the machinery within a biological cell that makes proteins. They used one archaeal and seven bacterial cultures grown to a cell density of approximately 108 to 109 cells/mL overnight. The microbes were detected using is a square-shaped microarray chip, with a dimension of approximately 25 mm and called the PhyloChip. The latest version is packed with more than a million individual probes and can be used to detect quickly, accurately, and comprehensively the presence of up to 50,000 different species of bacteria and archaea in a single sample from any environmental source, without the need of culturing.

One drawback to this method is that RNA binds much more tightly to the PhyloChip probes than is typical for DNA. This results in increased background noise and variability that can pose challenges. In response, the scientists developed a second PCR-free method in which the rRNA is replaced with a complementary DNA sequence (cDNA). The cDNA complement is then synthesized to create a double-stranded cDNA fragment that closely mirrors the properties of a PCR amplified 16S rRNA gene fragment. The PhyloChip is manufactured by Affymetrix Corp. (Santa Clara, CA, USA).

Gary Andersen, PhD, a microbial ecologist with Berkeley National Laboratory and senior author of the study, said, “Each method represents a simple and economical way to directly query microbial communities in natural environments and each offers the additional advantage of detecting the most metabolically active microbes in a community, the ones most likely to attenuate toxins, drive biogeochemical cycles, or proliferate in disease states.”

The study was published in the September 2011 edition of the journal Applied and Environmental Microbiology.

Related Links:

Lawrence Berkeley National Laboratory
Affymetrix





Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.